145 related articles for article (PubMed ID: 35557491)
1. Further Exploration of the Benzimidazole Scaffold as TRPC5 Inhibitors: Identification of 1-Alkyl-2-(pyrrolidin-1-yl)-1H-benzo[d]imidazoles as Potent and Selective Inhibitors.
Sharma S; L Pablo J; Tolentino KT; Gallegos W; Hinman J; Beninato M; Asche M; Greka A; Hopkins CR
ChemMedChem; 2022 Jul; 17(14):e202200151. PubMed ID: 35557491
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and characterization of novel N-heterocyclic-1-benzyl-1H-benzo[d]imidazole-2-amines as selective TRPC5 inhibitors leading to the identification of the selective compound, AC1903.
Sharma SH; Pablo JL; Montesinos MS; Greka A; Hopkins CR
Bioorg Med Chem Lett; 2019 Jan; 29(2):155-159. PubMed ID: 30538066
[TBL] [Abstract][Full Text] [Related]
3. Identification and optimization of 2-aminobenzimidazole derivatives as novel inhibitors of TRPC4 and TRPC5 channels.
Zhu Y; Lu Y; Qu C; Miller M; Tian J; Thakur DP; Zhu J; Deng Z; Hu X; Wu M; McManus OB; Li M; Hong X; Zhu MX; Luo HR
Br J Pharmacol; 2015 Jul; 172(14):3495-509. PubMed ID: 25816897
[TBL] [Abstract][Full Text] [Related]
4. Discovery of pyrroledione analogs as potent transient receptor potential canonical channel 5 inhibitors.
Zhang Z; Chen L; Tian H; Liu M; Jiang S; Shen J; Wang K; Cao Z
Bioorg Med Chem Lett; 2022 Apr; 61():128612. PubMed ID: 35143983
[TBL] [Abstract][Full Text] [Related]
5. Clemizole hydrochloride is a novel and potent inhibitor of transient receptor potential channel TRPC5.
Richter JM; Schaefer M; Hill K
Mol Pharmacol; 2014 Nov; 86(5):514-21. PubMed ID: 25140002
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of AC1903 analogs as potent transient receptor potential canonical channel 4/5 inhibitors and biological evaluation.
Chen L; Zhang Z; Tian H; Jiang S; Ji Y; Liu M; Shen J; Cao Z; Wang K
Bioorg Med Chem; 2022 Aug; 68():116853. PubMed ID: 35653869
[TBL] [Abstract][Full Text] [Related]
7. A benzothiadiazine derivative and methylprednisolone are novel and selective activators of transient receptor potential canonical 5 (TRPC5) channels.
Beckmann H; Richter J; Hill K; Urban N; Lemoine H; Schaefer M
Cell Calcium; 2017 Sep; 66():10-18. PubMed ID: 28807145
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for human TRPC5 channel inhibition by two distinct inhibitors.
Song K; Wei M; Guo W; Quan L; Kang Y; Wu JX; Chen L
Elife; 2021 Mar; 10():. PubMed ID: 33683200
[TBL] [Abstract][Full Text] [Related]
9. Involvement of TRP channels in the CO₂ chemosensitivity of locus coeruleus neurons.
Cui N; Zhang X; Tadepalli JS; Yu L; Gai H; Petit J; Pamulapati RT; Jin X; Jiang C
J Neurophysiol; 2011 Jun; 105(6):2791-801. PubMed ID: 21430274
[TBL] [Abstract][Full Text] [Related]
10. PIP
Ningoo M; Plant LD; Greka A; Logothetis DE
J Biol Chem; 2021; 296():100726. PubMed ID: 33933453
[TBL] [Abstract][Full Text] [Related]
11. Stereo-selective inhibition of transient receptor potential TRPC5 cation channels by neuroactive steroids.
Majeed Y; Amer MS; Agarwal AK; McKeown L; Porter KE; O'Regan DJ; Naylor J; Fishwick CW; Muraki K; Beech DJ
Br J Pharmacol; 2011 Apr; 162(7):1509-20. PubMed ID: 21108630
[TBL] [Abstract][Full Text] [Related]
12. Treatment with HC-070, a potent inhibitor of TRPC4 and TRPC5, leads to anxiolytic and antidepressant effects in mice.
Just S; Chenard BL; Ceci A; Strassmaier T; Chong JA; Blair NT; Gallaschun RJ; Del Camino D; Cantin S; D'Amours M; Eickmeier C; Fanger CM; Hecker C; Hessler DP; Hengerer B; Kroker KS; Malekiani S; Mihalek R; McLaughlin J; Rast G; Witek J; Sauer A; Pryce CR; Moran MM
PLoS One; 2018; 13(1):e0191225. PubMed ID: 29385160
[TBL] [Abstract][Full Text] [Related]
13. Discovery of pyridazinone derivatives bearing tetrahydroimidazo[1,2-a]pyrazine scaffold as potent inhibitors of transient receptor potential canonical 5 to ameliorate hypertension-induced renal injury in rats.
Xu Y; Ren Y; Zhang J; Niu B; Liu M; Xu T; Zhang X; Shen J; Wang K; Cao Z
Eur J Med Chem; 2024 Jun; 275():116565. PubMed ID: 38878518
[TBL] [Abstract][Full Text] [Related]
14. Review of Transient Receptor Potential Canonical (TRPC5) Channel Modulators and Diseases.
Sharma S; Hopkins CR
J Med Chem; 2019 Sep; 62(17):7589-7602. PubMed ID: 30943030
[TBL] [Abstract][Full Text] [Related]
15. Opposite regulatory effects of TRPC1 and TRPC5 on neurite outgrowth in PC12 cells.
Heo DK; Chung WY; Park HW; Yuan JP; Lee MG; Kim JY
Cell Signal; 2012 Apr; 24(4):899-906. PubMed ID: 22201561
[TBL] [Abstract][Full Text] [Related]
16. Molecular determinants of PKA-dependent inhibition of TRPC5 channel.
Sung TS; Jeon JP; Kim BJ; Hong C; Kim SY; Kim J; Jeon JH; Kim HJ; Suh CK; Kim SJ; So I
Am J Physiol Cell Physiol; 2011 Oct; 301(4):C823-32. PubMed ID: 21734191
[TBL] [Abstract][Full Text] [Related]
17. Activity dependent inhibition of TRPC1/4/5 channels by duloxetine involves voltage sensor-like domain.
Zimova L; Ptakova A; Mitro M; Krusek J; Vlachova V
Biomed Pharmacother; 2022 Aug; 152():113262. PubMed ID: 35691156
[TBL] [Abstract][Full Text] [Related]
18. Plasma membrane insertion of TRPC5 channels contributes to the cholinergic plateau potential in hippocampal CA1 pyramidal neurons.
Tai C; Hines DJ; Choi HB; MacVicar BA
Hippocampus; 2011 Sep; 21(9):958-67. PubMed ID: 20865744
[TBL] [Abstract][Full Text] [Related]
19. A greasy business: Identification of a diacylglycerol binding site in human TRPC5 channels by cryo-EM.
Storch U; Mederos Y Schnitzler M; Gudermann T
Cell Calcium; 2021 Apr; 97():102414. PubMed ID: 33930818
[TBL] [Abstract][Full Text] [Related]
20. Ca2+-calmodulin-dependent myosin light chain kinase is essential for activation of TRPC5 channels expressed in HEK293 cells.
Shimizu S; Yoshida T; Wakamori M; Ishii M; Okada T; Takahashi M; Seto M; Sakurada K; Kiuchi Y; Mori Y
J Physiol; 2006 Jan; 570(Pt 2):219-35. PubMed ID: 16284075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
